Objective: In this study, nine commercial Nucleic Acid Amplification Test Systems (NAATs) were evaluated for diagnostic performance of Mycobacterium tuberculosis complex (MTBC) from smear positive sputum species (SPss) and smear negative sputum specimens (SNss).
(SNss) obtained from the respiratory tract. 18 The sensitivity and specificity of these methods vary according to used techonolgy, quality of clinical samples and laboratory experiences. The Centers for Disease Control and Prevention (CDC) (Atlanta, Georgia, USA) has proposed algorithms for the detection of Mycobacterium tuberculosis complex (MTBC) in SPss and SNss. 17, 19 The detection limits of these assay systems based on nucleic acid amplification for MTBC were less than 10 cells per reaction.All other laboratory NAAT results have a good sensitivity for SPss; however, for SNss, the reported sensitivity varies considerably. 10 The DNA or RNA hybridization tests with labeled specific probes which have been described so far are not sensitive enough to be used for clinical specimens without culture .The polymerase chain reaction (PCR) as a rapid diagnostic technique has a potential test to overcome the limitations of sensitivity and specificity. From these systems, real-time PCR technology has replaced with the methodology of microbiological diagnosis using an automated system based on increased sensitivity. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] The aim of this study was to evaluate the diagnostic performance of the nine commercial NAATs (COBAS Amplicor MTB-Method A, GenProbe MTD -Method B, Cobas TaqMan MTB PCR-Method C, iCycler iQ real-time PCR-Method D, TaqMan PCR AB 5700-Method E, TaqMan PCR AB 7700-Method F, LightCycler® 480Real-Time PCR System-Method G, Rotor Gene Real Time PCR -Method H and the AdvanSure TB/NTM Real-Time PCR -Method I.
METHODS
Patient and sputum samples: One hundred-fifty sputum samples (60 SPss and 55 SNss) were obtained from Atatürk Chest Diseases and Thoracic Surgery Training and Research Hospital in Ankara,
INTRODUCTION
Tuberculosis (TB) is a life-threatening infectious disease, and one of the leading bacterial agents affecting to pulmonary system all over the world as well as in Turkey.
1 According to the World Health Organization's records, TB incidence in Turkey in 2009 was 25/100,000 with a mortality rate of 5 persons per 100,000 inhabitants, has a TB incidence of about 29/100,000, which is lower than WHO European region.
1,2 Smear microscopy is the cheapest, easiest and most rapid method for detection of mycobacteria from clinical specimens. However; it lacks specificity and low sensitivity (50%-70%) for pulmonary TB. 3, 4 Culture techniques are more sensitive than smear microscopy. Culture techniques have high sensitivity and antimicrobial susceptibility test can be done to the strain which was isolated after culturing.
4-9
Although culturing is a certain method for diagnosis, pathogen mycobacteria usually grow slowly and the earliest reproduction occurs within 3-6 weeks. 5 In order to prevent TB infection transmission and infection control, early diagnosis should be done and treatment should be started as soon as possible. For this reason, reliable and rapid methods are needed for TB diagnosis. Nucleic acid amplification test systems (NAATs) are able to detect TB bacilli within 3-5 hours.
8 Two of these NAATs are Cobas MTB (Roche, Switzerland) and GenProbe MTD (Gen-Probe, San Diego, CA) test which are used commonly for detecting TB bacillus from clinical samples. There are some other commercial tests for this purpose. [10] [11] [12] [13] [14] [15] [16] From the NAATs, Gen-Probe MTD and Cobas Amplicor MTB have been approved by US Food and Drug Administration (FDA) (Maryland, USA) for respiratory specimens from SPss in 1995 and 1998,respectively. [17] [18] [19] In 1999, the FDA approved the Gen Probe MTD test for use on acidfast bacilli (AFB) smear negative sputum specimens Sixty SPss were belong to the new pulmonary TB cases who received a confirmed diagnosis of TB based on a positive culture result. Fifty-five SNss whose specimens tested negative for acid-fast bacilli (AFB) on smear but clinically suspected TB infection. Sputum spot samples were collected triplicate before starting TB treatment. Each of the sputum samples were confirmed by direct smear microscopy separately. Then after, three sputum samples were processed and pooled, examined by smear microscopy, conventional culture, and the nine NAATs. All laboratory tests were done by an experienced laboratory expert and technologist in National Tuberculosis Reference and Research Laboratory. 
Sample processing
All sputum samples were decontaminated with the N-acetyl-L-cysteine (NALC)-NaOH method in 50 ml centrifuge tube. Two volumes of NALC-NaOH solution (4% NaOH, 1.45% Na-citrate, 0.5% NALC) were added to the specimen for digestion. After mixing, the mixtures were suspended at room temperature for 15 min. After this stage, 10 volumes of 6.7 mM phosphate buffer (pH 7.4) were added for dilution. The mixtures were centrifuged at 3,000 × g for 15 min at 4°C. The sediment of each specimen was re-suspended in 2 ml of the same phosphate buffer. 600 μl of the sediment was used smear microscopy and culture, 450 μl for rRNA extraction (for MTD test), 800 μl for DNA extraction (for eight NAATs) 29 .
Smear examination
All smear slides were stained by Ehrlich-Ziehl (EZN) method for detecting AFB and evaluated by an experienced microbiologist. The standard M. tuberculosis H37Rv (ATCC 27294) strain was used for quality control in the staining process.
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Culture
One hundred-fifty μl sediment was inoculated onto three Lowenstein-Jensen (LJ) slant for each sample.Slants were incubated at 37 °C for 8 weeks and bacterial growth was controlled twice a week at the first 3 weeks and then, were examined for growth weekly. A positive culture was confirmed by EZN microscopy and identified bycolony morphology, niacin and nitrate reductase test and PCR-RFLP.
5,10,30-33

DNA extraction
rRNA was extracted according to manufacturer's intstruction for GenProbe MTD. Magnapure automaticalnucleic acid extraction system (MagNA Pure LC Total Nucleic Acid Isolation Kit, Roche Diagnostics) was used for DNA extraction from processed sputum samples for the other eight NAATs.
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NAAT tests
All nine NAATs were performedin accordance with the manufacturer's instructions. [36] [37] [38] [39] [40] [41] For each NAAT; positive and negative amplification controls were used. Technical characteristics and mechanism of these systems are shown in Table 2 . 21 Each NAAT was performed by trained laboratory expert for test system. 
Statistical Analysis
The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the nine NAATs were calculated by using the culture results as the reference standards (38). Statistical comparisons of the nine methods were performed by using the chi-square test; a P value of <0.05 was considered significant the analysis was performed by using of SPSS, version 14.0 (SPSS).
42
RESULTS
A total of 115 sputum samples (60 SP and 55 SN)
collected from 115 patients were tested in this study. All samples were examined by smear examination, LJ culture and nine NAATs. Of 60 SPss were smear positive, culture positive and clinical data positive. Thirteen of 55 SNss were culture positive ( Table 3) .
Rests of SNss (42/55) were found negative for culture and clinical data but tuberculin skin test result was higher than 15 millimeters for each patient. The rest of SNss (42/55) were clinically positive. When LJ culture results were taken as gold standard; the positivity rates of the method A, B, C, D, E, F, G, H and I were was found 98.33%, 93.33%, 96.7%, 100%, 93.3%, 100%, 100%,100% and 100% respectively for SPss. It was found as 53.84% (7/13) for methods A, B, D, E, G, I; 38.5% (5/13) for methods C and H, 61.5% (8/13) for method F in SNss (Table 3) . When LJ culture results were accepted as a reference method, the sensitivity rates of the methods A, B, C, D, E, F, G, H, I were 100 % for SPss. The sensitivity was 53.8% for the methods A, B, D, E, G and I; 38.5% for the method C and H; 61.5% for the method F for the method I in SNss. There were no statistical significant differences between the nine NAATs (p≥0.05). The specificity was 100% for all nine NAATs in SNss. Statistical analysis showed that there were no significant differences among the nine NAATs. The P values were 0.145 for smear-positive plus culture-positive specimens, 0.490 for smear-negative but culture-positive specimens, and 0.220 for smear-negative plus culturenegative specimens. 
PPV 100 100 100 100 100 100 100 100 100 
DISCUSSION
In recent years, many NAATs were developed for the rapid diagnosis of MTBC from clinical samples and determination of drug resistance. Sensitivity and specificity rates of these tests were changing to type patient group, quality of the clinical samples, processing method of samples, DNA isolation and reference methods. [11] [12] [13] [14] [15] [16] NAATs have a good sensitivity for smear-positive specimens. However; the sensitivity rates have been varied considerably for SNss in the reported studies. [20] [21] [22] [23] [24] [25] [26] [27] [28] For most commercial tests, the assay sensitivities (87.5%-100%) seem to be satisfactory for AFB SPss, but the sensitivities (50.0% to 70.8%) varied greatly for AFB SNss. [11] [12] [13] [14] [15] [16] Within these NAATs; Cobas Amplicor MTB and GenProbe MTD systems were commonly used for rapid diagnosis of MTBC in sputum samples. 9, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Recently, several commercial NAAT system based on real-time PCR is used for routine diagnosis. Real-time PCR has several advantages, such as a short turnaround time, a low contamination rate due to the use of a closed system and the ability to quantify the bacterial load. [19] [20] [21] [22] [23] [24] [25] [26] In our study, we aimed to evaluate the nine NAATs in their ability to detect MTBC in SPss and SNss. This sensitivity value (100%) was comparable with the reported studies. 11-16, 21-27, 43-46 For detection of MTBC in SNss, our results were comparable with the results obtained by published data. The sensitivity of C and H method was the lowest among those (51% to 71.7%; average, 59.5%) reported for the NAATs. 11-16, 21-27, 43-46 For SNss, the sensitivity rates of the nine NAAT methods were correlating with the results obtained by published data. The sensitivity rates were very low for SNss. The specifity and NPV value could not be determined due to the absence of the negative sample result group for SPSss.
Negative results obtained from culture-positive specimens by molecular amplification assays are normally explained by a low load of mycobacteria and an unequal distribution of mycobacteria in the test specimens. 21 It was noted that the extraordinary low sensitivity of the nine NAATS for smear negative samples comparison with published studies. The specifity and NPV values were not calculated , because of all samples were culture positive in SPss. While specifity and PPV values of nine NAATs were found 100%, the sensitivity and NPV values were differ as NAAT method in SNss. In our study, the lowest sensitivity for SNss was detected with method C and H (38.46%). According to our experience, the nine NAAT systems do not have a prominent ability to detect lower loads of MTBC in SNss. No significant differences were observed among the results of the nine NAATs, which are acceptable for direct detection of M. tuberculosis complex in SNss. As a result, the nine NAATS systems performance was found ineffective for SNss. Our study showed lower sensitivity than the previously reported data, especially for the Cobas Amplicor PCR. Until now, the diagnostic sensitivity of commercially available kits, including the Cobas Amplicor PCR, for detection of M. tuberculosis had been reported to be over 80%. 11, 15, 16, 21 The performance of the nine NAAT system can use only SPss. As bacillus amount is very low in SNss; determination capacity of molecular methods is also low.
CONCLUSION
Due to the results of this study and previous reports, it is obvious that molecular methods are still not as sensitive as culture. The major strengths and weaknesses of a NAAT system should be entirely understood before the system is adopted in the routine laboratory. NAATs should be interpreted within the context of the patient's signs and symptoms, and should always be performed in conjunction with AFB smear and culture. As a result, nine NAATs might be useful for detecting MTBC from SPss, but not effective for SNss. 
